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Abstract 
Five lactic acid bacterial isolates from the intestinal tract of Nile Tilapia (Oreochromis niloticus) were tested for 
their antagonistic activity against common human pathogens. Only three were identified using 16S rRNA gene 
sequencing as Pediococcus pentosaceus (isolates TI-8 and TI-11) and Enterococcus avium (TI-17) showing 
99% homology. Among the isolates, TI-8 and T1-11 (P. pentosaceus) viable cell cultures were found to have 
the highest inhibitory activity against Escherichia coli ATCC 25922, surpassing that of the positive control, 
Tetracyline. Though showing significant inhibition also to Pseudomonas aeruginosa BIOTECH 1335, 
Staphylococcus aureus BIOTECH 1582, Salmonella enteriditis BIOTECH 1963, Salmonella typhimurium 
BIOTECH 1826, and Vibrio cholerae BIOTECH 1967, T1-17 (Enterococcus avium) is not effective against S. 
aureus BIOTECH 1582. On the other hand, T1-8 and T1-11 (P. pentosaceus) cell free supernatant cultures 
exhibited inhibitory activity against P. aeruginosa BIOTECH 1335, S. aureus BIOTECH 1582, S. enteriditis 
BIOTECH 1963, S. typhimurium BIOTECH 1826, and V. cholerae BIOTECH 1967.   
------------------------------------------------------------------------ 
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The LAB isolate T1-17 (E. avium) exhibited  an  inhibitory  activity against S. enteriditis BIOTECH and V. 
cholerae  BIOTECH 1967. T1-11 (P. pentosaceus) was susceptible to Tetracycline and Amoxicillin; T1-8 (P. 
pentosaceus)  was susceptible to Amoxicillin and Cephalexin; and   T1-17 (E. avium) was susceptible to 
Amoxicillin.    
Keywords: antibacterial; human enteric pathogen; Lactic Acid Bacteria; Nile tilapia . 
1.  Introduction  
Probiotic technology notably changed the human perception concerning microorganisms. These probiotic 
products had been introduced to various food and drugs and represent a huge proportion of the biotechnology 
products available today. Moreover, they have been widely exploited due to their beneficial effects specifically 
for the improvement of human health. 
Probiotics are viable microbial supplement which, when ingested in sufficient amount, promotes improvement 
in the indigenous micro-flora of the gastrointestinal tract [1,2]. The most common type of beneficial 
microorganism used as a probiotic is Lactic Acid Bacteria, which include Lactobacillus acidophilus, 
Lactobacillus casei and Lactobacillus plantarum [3]. 
Live lactic acid bacteria intake through dairy products have myriad beneficial effects on the gastrointestinal tract 
of human beings ranging from correction of lactose malabsorption, alleviation of viral and drug induced 
diarrhea, post-operative pouchitis, irritable bowel syndrome, inflammatory bowel syndrome, anti-neoplastic 
effects on human cell line, maintenance of normal insulin level in blood and also helpful to enhance the 
absorption of fatty acids through intestine. LAB produce these beneficial effects by restoration of normal 
intestinal flora, elimination of intestinal pathogens, reinforcement of intestinal barrier capacity to foreign 
antigens, stimulation of nonspecific immunity such as phagocytosis, stimulation of humoral immunity and 
production of anti-inflammatory products[4,5,6]. Beneficial microorganisms also have positive effect on lactose 
intolerance and malabsorption. Kinova and his colleagues [7]    described these beneficial effects exhibited by 
Lactobacillus present in fermented milk products. Also, a review described that consumption of yogurt 
containing Lactobacillus bulgaricus and Streptococcus thermophiles alleviate lactose intolerance through their 
enzyme lactase when the product reaches the intestinal tract[8].  
Lactic acid bacteria have been isolated and characterized from different sources such as vegetable wastes and 
fish intestines using species-specific PCR techniques and 16S rDNA/ rRNA gene sequencing[9]. Several types 
of researches have also revealed the presence of probiotic bacteria like Bacillus spp. and Lactobacillus spp. from 
the intestinal tract of common carp and the gut of blue swimming crab that are known to inhibit several 
pathogens[3,10]. Moreover, Flores and Novoa[11], investigated the effects of lactic acid bacteria isolated from 
the intestinal tract of Nile tilapia (Oreochromis niloticus) as a growth promoter. Their study revealed that lactic 
acid bacterial isolates namely, Enterococcus faecium, Enterococcus durans, Leoconostoc sp., Streptococcus sp. 
I and II have the potential to become native growth promoter comparable to Lactobacillus acidophilus which is 
an already commercialized probiotic. 
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In addition, several studies investigated the role of LAB as pathogen antagonist in fish and crustaceans which 
stabilize disease management in the aquaculture sector.   Lim and his colleagues [12]. reported four probiotic 
bacterial isolates obtained from cultured red tilapia namely, Paenibacillus barcinonensis strain D12, 
Paenibacillus sp. strain D14, Staphylococcus cohnii strain B11 and Bacillus megaterium strain E28 which 
showed antibacterial activity against Vibrio alginolyticus ATCC 33839, Aeromonas salmonicida, and 
Aeromonas hydrophila ATCC 35654 under in vitro conditions.  
However, there are limited researches that investigated the use of LAB isolates from fishes to directly target an 
extensive range of human enteric pathogens, thus, this study was undertaken to isolate and identify useful lactic 
acid bacteria from the intestinal microbiota of Nile tilapia (Oreochromis niloticus) as an inhibitor of different 
pathogens that attack the human gut and cause a wide range of human enteric maladies.   
2.  Methodology 
2.1. Research Design 
The experimental method of research was used  in isolating and identifying lactic acid bacteria from intestinal 
tract of Nile Tilapia and their potentials as pathogen antagonists.  
2.2. Sample Preparation and Plating 
A total of ten (10) Tilapia, weighing 150 – 200 grams, regardless of sex, caught from Dukma River, a portion of 
Pampanga River, in Macabebe, Pampanga, were aseptically dissected to obtain their intestinal tract. Before 
dissection, the abdominal surface of each of the fish sample was scrubbed with rubbing alcohol. The entire 
intestinal tract was then cleansed with sterile 0.9% saline solution. 
 Consequently, twenty-five grams of the intestinal tract was mixed into two hundred twenty-five mL of sterile 
dilution water (0.1% peptone water) and homogenized for two minutes using a blender.  Subsequently, a serial 
dilution was prepared to obtain countable colonies ranging from the original mixture 1:10 to 1:1000 or higher as 
needed. One mL of each dilution prepared was seeded and spread into MRS Agar plates in triplicate, then 
incubated in an inverted position at 35±0.5°C for 48 hours under micro-aerophilic condition. 
2.3.Culture Selection and Initial Identification 
After incubation, potential colonies of lactic acid bacteria were randomly picked by their colonial morphology. 
Selected colonies were grown in pure culture using the same media and subjected to biochemical analysis. Gram 
staining and catalase test were performed for preliminary identification of the selected isolates.  
Lactic acid bacteria are gram positive and catalase negative[13]  (Sonomoto and Yokota, 2011) thus, only the 
gram-positive and catalase negative isolates were screened for in-vitro antagonistic effect against selected 
human enteric pathogens. 
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2.4. Preparation of Pure Culture 
Suspected colonies were streaked into MRS Agar plate for culture purification which was done three (3) times, 
to ensure that only a single strain of bacteria will be obtained in each of the chosen colonies.  
2.5. Preparation of Isolate 
A loopful of the pure culture bacterial isolates was inoculated into test tubes containing ten (10) mL MRS broth 
(HiMedia), and were incubated at 35±0.5°C for about 24 hours. After incubation, the broth cultures were 
transferred into sterile microtubes containing one (1) mL MRS broth and subsequently incubated for eighteen 
(18) hours. Afterward, each microtube was subjected to a ten (10) minute centrifugation using Sigma® 1-14 
High-Speed Centrifuge to obtain a cell-free supernatant at 12,000 x G. 
2.6. Inhibitory Activity of the LAB cell-free supernatants against Selected Pathogens  
The antagonistic effects of the LAB isolates against selected human enteric pathogens were assessed using the 
Agar- well Diffusion Assay (Guevarra, 2005). 
The selected strains of human enteric pathogens, namely, E. coli ATCC 25922, S. typhimurium BIOTECH 1826, 
S. enteriditis BIOTECH 1963, V. cholera BIOTECH 1967, P. aeruginosa BIOTECH 1335, and S. aureus 
BIOTECH 1582 were purchased from Microbiology Department of the University of the Philippines Manila and 
at the National Institute of Molecular Biology and Biotechnology, University of the Philippines Los Baṅos, 
Laguna. A loopful of each bacterium was inoculated heavily into five (5) mL sterile 0.1% peptone water and 
then compared to a McFarland standard to give an approximately 1.5x108 CFU/mL of the test bacterium.Using a 
sterile cotton swab, the entire surface of Mueller-Hinton (MH) agar (HiMedia) was inoculated with the test 
organism previously grown in 0.1% peptone water. The inoculum was then allowed to dry on the surface of the 
medium for about fifteen (15) minutes. Consequently, the MH agar plate was divided into three (3) quadrants 
using a marker at the bottom of the plate. Wells were made using a cork borer, positioned at the center of each 
quadrant on the surface of MH agar plate.  
Thirty (30) µL of the treatment or cell-free supernatants previously prepared was dropped in each agar well 
along with the positive control- Tetrcycline. Then, the plates were incubated at 35±0.5°C for 24 hours The zone 
of growth inhibition as indicated by clear zones or halo zones was measured in millimeters after the incubation 
period. The growth of the test organisms treated with the supernatants suspected to have bacteriocin-like 
inhibitory potentials was recorded.  
2.7. Inhibitory Activity of the LAB Viable Cell Culture against Selected Pathogens  
Using the same procedure for antibacterial screening of the cell-free supernatants, viable cell cultures were also 
assessed for competitive exclusion as inhibitory against the selected human pathogens. In each well of 
previously inoculated MH agar (HiMedia) plates, about 30 µL of the 24-hour old culture of LAB isolates were 
introduced. The plates were then incubated at 35±0.5°C for 24 hours, after which, the zones of inhibition 
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produced as indicated by clear zones or halo zones were measured in millimeters. The results were noted side by 
side with the negative control, 30 µL sterile MRS broth. 
2.8. Antibiotic Sensitivity Assay 
The same procedure was adopted from the in-vitro antibacterial screening. The lactic acid bacterial isolates 
served as the test organisms which were subjected to antibiotic sensitivity screening against selected antibiotics 
namely, T1 – Tetracycline, T2 – Amoxicillin, T3 – Cephalexin, T4 – Ciprofloxacin and T5 – Cefixime.   
Each lactic acid bacterial isolates were subjected to the above-mentioned treatments. Interpretation of the results 
was based on Clinical and Laboratory Standards Institute document M100-S24 (CLSI, 2014). Only the negative 
control (distilled water) was used on a separate plate, no positive control was used. 
2.9. Molecular Identification of Bacterial Isolates 
LAB isolates that exhibited inhibitory activity against the selected pathogens were subjected to molecular 
identification using the 16S rRNA gene sequencing at the Philippine Genome Center, University of the 
Philippines-Diliman, Quezon City.   
DNA material was extracted from a pure culture of the pre-identified lactic acid bacterial isolate that exhibited 
significant antibacterial activity using a DNA extraction Kit. It was amplified using 16S universal forward and 
reverse primers. The PCR product was purified and run in 1.5% agarose gel.  Sequencing of around 750 to 1500 
bp from the PCR product was done using Capillary Sequencing. 
MEGA Blast 5 nucleotide sequence software was used for the analysis of the sequences and compared with the 
published sequences in GenBank from National Center for Biotechnology Information (NCBI). 
2.10. Statistical Analysis 
Data were statistically analyzed using the one-way analysis of variance (ANOVA) of the Completely 
Randomized Design and the Least Significant Difference test. 
3. Results and Discussion 
3.1. Culture Selection and Initial Identification of the Isolates 
A total of twenty-one (21) colonies were selected and sub-cultured. However, only eighteen (18) colonies were 
able to grow during culture purification (Table 1).   
Gram’s Staining and Catalase Test revealed that only the isolates with the codes TI-1, TI-8, TI-11, TI-17 and TI-
18 were initially presumed to be lactic acid bacteria being gram positive and catalase negative (Sonomoto and 
Yokota, 2011). 
 These five (5) presumptive lactic acid bacteria were assessed for their inhibitory potential as part of the 
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experiment in this study before validation of their identity via the molecular method. Since colonial morphology 
was not part of the project, random picking of colonies was done instead (Table 1). 
Table 1: Gram’s staining and catalase test result of the selected colonies 
Code No. Gram’s Stain Catalase Test Code No. Gram’s Stain Catalase Test 
TI-1 (+) (-) TI-10 (-) (+) 
TI-2 (-) (+) TI-11 (+) (-) 
TI-3 (-) (+) TI-12 (+) (+) 
TI-4 (-) (+) TI-13 (-) (-) 
TI-5 (-) (-) TI-14 (-) (+) 
TI-6 (-) (+) TI-15 (-) (+) 
TI-7 (-) (+) TI-16 (-) (-) 
TI-8 (+) (-) TI-17 (+) (-) 
TI-9 (-) (+) TI-18 (+) (-) 
3.2. Inhibitory Activity of the LAB isolates against E. coli ATCC 25422  
The mean zones of inhibition produced around the agar well applied with 30 µL of the broth cultures containing 
viable LAB cells and LAB supernatants, respectively, are shown in Figure 1a. Of the five LAB isolates, only 
four were tested for inhibitory activity due to the difficulty in maintaining cell culture of T1-18.  Among the 
four isolates in the viable cell cultures, TI-8 obtained the highest inhibitory mean of 13.33 mm followed by TI-
11 (12.67 mm), tetracycline (8.667 mm) and TI-17 (8.00 mm).  Analysis of variance (ANOVA) revealed that 
these were significantly higher than the distilled water (negative control) and TI-1.  In the cell- free supernatant, 
the zones of inhibition were relatively smaller in diameter as compared to that in viable cell culture, with 6.333 
for TI-8, TI-11 and TI-17 and 7.667 for tetracycline. ANOVA revealed no significant difference among the 
mean zones of inhibition at 95% confidence level. 
 
Figure 1:  Antagonistic effect of viable cell cultures and supernatants of LAB isolates against   E. coli ATCC 
25922 
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3.3. Inhibitory Activity of the LAB isolates against S. typhimurium BIOTECH 1826 
As shown in Figure 1b, among the four viable cell culture isolates, TI-11 obtained the highest mean (11.00 mm) 
followed by TI-17 (10.33 mm) and TI-8 (10.00 mm). They are significantly lower than the inhibitory activity of 
tetracycline but significantly higher than distilled water (6.00 mm). TI-1 was comparable with the negative 
control, signifying the absence of inhibitory activity against the strain of S. typhimurium.     
In the cell-free supernatants, TI-8 obtained the highest inhibition activity (9.667), followed by TI-11 (9.333) and 
TI-17 (9.000). They are comparable to each other, however, significantly different with the positive and 
negative controls. Significant differences among the means produced by the viable cell culture and cell-free 
supernatants were observed. The results imply that T1-8, T1-11, and T1-17 are potential pathogen antagonists. 
 
Figure 2:  Antagonistic effect of viable cell cultures and supernatants of LAB isolates against 
S. typhimurium BIOTECH 1826 
3.4. Inhibitory Activity of the LAB isolates against S. enteriditis BIOTECH 1963 
There was no significant difference among the inhibitory zones of the viable LAB culture isolates TI-11 (7.667 
mm), TI-8 (7.33) and TI-11 (7.33) as presented in Figure 1c. Although they were significantly lower than 
tetracycline, they were significantly higher than the negative control, signifying inhibitory potential against S. 
enteriditis BIOTECH 1963. 
Among the cell-free supernatant cultures, T1-8 (9.333 mm) and T1-11 (9.000 mm) were comparable with each 
other. They were significantly lower than the T+, but significantly higher than the negative control (6.000 mm) 
and T1 (6.000 mm). 
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Figure 3:  Antagonistic effect of viable cell cultures and supernatants of LAB isolates againstS. enteriditis  
BIOTECH 1963. 
3.5. Inhibitory Activity of the LAB isolates against V. cholerae BIOTECH 1967 
Viable LAB cell cultures and cell free supernatant cultures of  TI-8, T1-11 and T1-17 did not significantly differ 
as to their inhibitory activity as presented in Figure 1d. Though they were significantly lower than tetracycline, 
they were significantly higher than the negative control and T1-1. 
The relatively great difference between tetracycline and the isolates may be because the compounds responsible 
for the inhibitory potential from each isolate are not yet properly isolated or purified.  
 
Figure 4: Antagonistic effect of viable cell cultures and supernatants of LAB isolates against  V. cholerae 
BIOTECH 1967 
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3.6. Inhibitory Activity of the LAB isolates against P. aeruginosa BIOTECH 133  
Among the four isolates, TI-11 obtained the highest mean (13.33 mm) followed by TI-17 (12.67 mm) and TI-8 
(10.33 mm) as shown in Figure 1e. TI-1 did not display any sign of inhibition against the strain of P. 
aeruginosa. Signifying the absence of inhibitory activity against the strain of P. aeruginosa. The tetracycline 
produced 16.67 mm zone of inhibition which is significantly higher than the isolates. However, the inhibition 
difference is not relatively large which suggests that isolates TI-8, and TI-11 elicited  strong inhibitory activity 
against P. aeruginosa. In the cell free supernatant, TI-8 obtained the highest inhibition with the mean of 13.33, 
followed by TI-11 with a mean of 12.00.  
 
Figure 5: Antagonistic effect of viable cell cultures and supernatants of LAB isolates against  P. aeruginosa 
BIOTECH 133 
3.7. Inhibitory Activity of the LAB isolates against S. aureus BIOTECH 1582 
As presented in Figure 1f, the viable cell cultures of TI-8 and TI-11 have comparable means of inhibition but 
were found to be significantly lower than the positive control but higher than TI-17. No significant difference 
was observed among TI-1 and negative control. 
In the cell- free supernatant cultures, the same trend with the viable cell culture was observed, however, T1-17 
was comparable with T- and T1, signifying no inhibitory activity against the strain of S. aureus.   
This relatively great difference between the positive control and the isolates may be because the compounds 
rsponsible for the inhibitory potential from each isolate are not yet completely isolated or purified.  
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Figure 6:  Antagonistic effect of viable cell cultures and supernatants of LAB isolates against S. aureus 
BIOTECH 1582 
There were varying results observed on the inhibitory activity of lactic acid bacterial isolates against the test 
organisms, suggesting that the isolates have selective inhibitory potential.  In fact, bacteriocin, an inhibitory 
protein synthesized by a bacterium E. coli, which is a part of the normal microbiota of the gastro-intestinal tract 
of human and other endotherms has a relatively narrow bactericidal spectrum which is a beneficial characteristic 
if the isolates will be tested as probiotic supplement [14,15]. 
Moreover, bacteriocins produced by Gram-positive bacteria, seldom inhibit commonly encountered 
enteropathogenic bacteria [16]   and are usually inactive against most Gram-negative bacteria due to their outer 
membrane components that interfere the entry of certain hydrophobic solutes and macromolecules [17].  As 
normal flora of the gut, E. coli has many beneficial effects, such as vitamin K synthesis  and inhibition of 
harmful bacteria from being established in the intestine via bacteriocin production and through other known 
mechanisms[17].  
Several studies revealed that most lactic acid bacteria have inhibitory properties against several enteric 
pathogens, i.e, Salmonella spp. and E. coli, which may be   accounted to the metabolites they produce such as 
enzymes, organic acids, bacteriocin and other natural antibiotics [1]  (Sharma, 2011). Rauta and his colleagues 
[9]  demonstrated that Lactobacillus delbrueckii has high inhibitory effect against Proteus vulgaris, Bacillus 
subtilis, Pseudomonas aeruginosa, E. coli and Klebsiella pneumonia.  Myllyluoma and his colleagues [18]   also 
showed that Lactobacillus rhamnosus inhibits growth of H. pylori, the causative agent of gastric ulcer. Similar 
undertaking by Lawalata and his colleagues [19]   revealed that Pediococcus acidilactici, isolated from an 
Indonesian traditional fermented fish product, exhibits a strong activity against pathogenic bacteria. Moreover, 
two studies showed that lactic acid bacteria from the intestines of the Nile tilapia (O. niloticus) such as 
Enterococcus faecium, Leuconostoc mesenteroides, Lactobacillus fermentum, Lactobacillus plantarum, and 
Enterococcus durans possess antibacterial activity against fish pathogens [11]. 
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3.8. Antibiotic Susceptibility of the LAB Isolates 
The susceptibility of the lactic acid bacterial isolates was tested against selected antibiotics.  
As presented in Table 2, TI-1 was found to be susceptible to tetracycline and amoxicillin with means of 19.33 
and 27.33 mm, respectively and resistant to the remaining test antibiotics. 
 The LAB isolate TI-8 was found to have an intermediate susceptibility to tetracycline with a mean of 12.22, 
susceptible to both amoxicillin and cephalexin with   means of 36.33 and 20.33, respectively, and resistant to 
ciprofloxacin, cefixime and chloramphenicol with their respective mean inhibition of 8.67, 8.33 and 6.00 mm.  
 Moreover, TI-11 was found to have intermediate susceptibility to tetracycline (14.00 mm), susceptible to 
amoxicillin (35.33 mm) and cephalexin (22.00 mm), and resistant to ciprofloxacin, cefixime and 
chloramphenicol. Lastly, TI-17 was found to be resistant to tetracycline, cephalexin, cefixime and 
chloramphenicol, whereas intermediate to ciprofloxacin (16.67 mm) and susceptible to amoxicillin with a mean 
of 30.33. The results indicate that Tetracycline and Amoxicillin are effective against the cultures T1-1; 
Amoxicillin and Cephalexin are effective against the cultures T1-8 and T1-11 and Amoxicillin is effective 
against T1-17 culture. 
Table 2: Susceptibility of LAB isolates against selected antibiotics 
 Mean Inhibition Zones (mm) 
Treatments TI-1 TI-8 TI-11 TI-17 
Tetracycline 19.33 S 12.33 I 14.00 I 7.33   R 
Amoxicillin 27.33 S 36.33 S 35.33 S 30.33 S 
Cephalexin 6.00  R 20.33 S 22.00 S 6.00   R 
Ciprofloxacin 6.00  R 8.67  R 10.00 R 16.67 I 
Cefixime 6.00  R 8.33  R 6.00  R 6.00   R 
Chloramphenicol 6.00  R 6.00  R 6.00  R 6.00   R 
TI – Tilapia Intestine; Reference standard by CLSI[20], 2014 
 Susceptible (S) Intermediate (I) Resistant (R) 
Tetracycline (30µg) ≥ 15 12-14 ≤ 11 
Amoxicillin (10µg) ≥ 17 14-16 ≤ 13 
Cephalexin (30µg) ≥ 18 15-17 ≤ 14 
Ciprofloxacin (5µg) ≥ 21 16-20 ≤ 15 
Cefixime (5µg) ≥ 19 16-18 ≤ 15 
Chloramphenicol (30µg) ≥ 18 13-17 ≤ 12 
 
3.9. Molecular Identification of the LAB Isolates 
The amplicon of the target gene in the three isolates is indicated by bright bands (Figure 2). Isolate TI-1 was not 
included in DNA extraction due to difficulty in maintaining the culture. The isolate with code TI-1 did not yield 
amplicon, thus, only TI-8, TI-11, and TI-17 were subjected to sequencing.  
International Journal of Sciences: Basic and Applied Research (IJSBAR) (2018) Volume 41, No  2, pp 75-90 
 
86 
 
 
Figure 7:  Amplicons of the target gene from the lactic acid bacterial isolates 
Sequence analysis of the 16S rRNA gene (Figure 3a-c) revealed that TI-8 and TI-11 are both Pediococcus 
pentosaceus with an identity of 99% suggesting that they are different strains. Further, TI-17 was revealed to be 
Enterococcus avium with an identity of 99%.   
 
Figure 8: BLAST hits of the query TI-8 showing similar descriptions to P. pentosaceus BSS1375 
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Figure 9: BLAST hits of the query TI11 showing similar descriptions to P. pentosaceus ZZU64 
 
Figure 10: BLAST hits of the query TI17 showing similar descriptions to E. avium IN3633  
3.10. Phylogenetic Tree of the Isolates using Clustal Omega Neighbor-Joining Algorithms  
Comparison of the partial 16S rRNA of the O. niloticus intestine associated LAB isolates Pediococcus 
pentosaceus (TI-8), Pediococcus pentosaceus (TI-11) and Enterococcus avium (TI-17) with the existing LAB 
sequence data from Genbank showed that all strains lay in the same clade. The three strains had a 99% identity 
with known Pediococcus pentosaceus and Enterococcus avium.  
A phylogenetic tree of these LAB isolates was built using the Clustal Omega neighbor-joining algorithms 
without distance correction using different sequences from the first two BLAST query results. It can be 
observed that the two Pediococcus pentosaceus isolated from O. 
 niloticus were closely related with their common ancestor. The values indicate the dissimilarity of the isolates 
in which the higher the score, the lower the similarity. Moreover, the Enterococcus avium (TI-17) is a close 
relative of the former as compared to the other Enterococcus sp. This can be assumed that the relatedness might 
be due to the environment that the ancestor of the isolates inhabited, and that other Enterococcus sp. diverged 
differently because of the environment from different locale where they were isolated.  
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Figure 11:  Phylogenetic neighbor-joining tree of the isolates based on partial 16S rRNA gene sequence in 
comparison with the existing NCBI database 
 4. Summary and Conclusion 
The isolation of the three Lactic Acid Bacteria from the Nile Tilapia (Oreochromis niloticus) is a welcome 
development in the drug industry, mainly as possible sources of bacteriocin, to fight against human pathogens. 
The two strains of Pediococcus pentosaceus and Enterococcus avium were found to be of potential source of 
antagonistic substances against some common human pathogens. 
Among the isolates, TI-8 and T1-11 (P. pentosaceus) viable cell cultures were found to have the highest 
inhibitory activity against E. coli ATCC 25922, surpassing that of the positive control, Tetracyline, though 
showing significant inhibition also to P. aeruginosa BIOTECH 1335, S. aureus BIOTECH 1582, S. enteriditis 
BIOTECH 1963, S. typhimurium BIOTECH 1826, and V. cholerae BIOTECH 1967,  T1-17 (Enterococcus 
avium) is not effective against Staphylococcus aureus BIOTECH 1582. 
On the other hand, T1-8 and T1-11 (P. pentosaceus) cell free supernatant cultures exhibited the inhibitory 
activity against P. aeruginosa BIOTECH 1335, S. aureus BIOTECH 1582, S. enteriditis BIOTECH 1963, S. 
typhimurium BIOTECH 1826, and V. cholerae BIOTECH 1967. The LAB isolate T1-17 (E. avium) exhibited 
the inhibitory activity against S. enteriditis BIOTECH and V. cholerae BIOTECH 1967.  
LAB isolates T1-8, T1-11, and T1-17 were susceptible to Amoxicillin, whereas LAB isolates T1-8 and T1-11 
were susceptible to Cephalexin and possess intermediate susceptibility to Tetracycline. T1-17 had an 
intermediate susceptibility to Ciprofloxacin 
5. Recommendation 
The result is a research breakthrough that need further verification on the following: 
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a. Protein and proteinase treatment of the cell free supernatants should be undertaken to validate further 
that the inhibitory activity is caused by the protein of peptide; 
b. The gene responsible for the production of the anti-biotic protein or peptide be isolated and determined; 
and 
c. The isolates should also be tested to other pathogens aside from bacteria. 
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